BB
Bhupendra Bhaskar Marliwar
About Bhupendra Bhaskar Marliwar
Data last updated:
Bhupendra Bhaskar Marliwar has 16 years in corporate governance. Holds Director role. Currently with 3 companies, including Signity Pharmaceuticals Private Limited and Tara Lifescience Private Limited. Formerly with 3 companies, such as 5 Milligram Pharmaceuticals Private Limited and Adwitaa Iron And Steel Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Director | 13 Sep 2010 | 2010 | Active | |
| Director | 12 Apr 2017 | 2017 | Active | |
| Director | 29 Sep 2017 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Director | 06 Jun 2023 | 2023 | Active | |
| Director | 09 May 2022 | 2016 | Active | |
| Director | 27 May 2015 | 2015 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhupendra Bhaskar Marliwar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhupendra Bhaskar Marliwar
Bhupendra Bhaskar Marliwar has 16 years in corporate governance. Holds Director role. Currently with 3 companies, including Signity Pharmaceuticals Private Limited and Tara Lifescience Private Limited. Formerly with 3 companies, such as 5 Milligram Pharmaceuticals Private Limited and Adwitaa Iron And Steel Private Limited. Engaged in General Business. Contributes to corporate operations.
Bhupendra Bhaskar Marliwar is associated with 3 companies as Director.
Bhupendra Bhaskar Marliwar has expertise in General Business.
Bhupendra Bhaskar Marliwar has 16 years in corporate governance.